China accounted for over a third of US imports of critical medical supplies in 2019—a category that includes surgic… https://t.co/BiZ62qnwoK
Customer Logins
Obtain the data you need to make the most informed decisions by accessing our extensive portfolio of information, analytics, and expertise. Sign in to the product or service center of your choice.
Customer Logins
Our pricing and reimbursement research presented at ISPOR Europe
14 November 2018
Milena Izmirlieva
In research, presented at the ISPOR Europe meeting in Barcelona on 13 October, Associate Director Milena Izmirlieva examines the impact of securing marketing approval under an expedited pathway on pricing and reimbursement outcomes.
Related Posts
-
-
-
-
-
-
-
-
Explore
RELATED INDUSTRIES & TOPICS
Follow Us
Listen to Milena Izmirlieva from our Life Sciences team talk about bed shortages. https://t.co/epnfyXGUMH
RT @CraigFerriman: On @AJInsideStory: How should drug companies handle the #CoronavirusPandemic? What must be done to ensure they don't put…
As the UK government steps up its preparedness plan for any national spread of the COVID-19 outbreak, it has suspen… https://t.co/9A4TRwzEEB